MPT0L145 is a highly potent inhibitor of PIK3C3 with a Kd value of 0.53 nM with minor activity to FGFR that interferes autophagy flux in FGFR-activating bladder cancer cells [16]. Here, PIK3C3 is linked to urinary bladder carcinoma.